Alexion Reports Fourth Quarter and Full Year 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Nasdaq, S&P 500 futures climb ahead of key jobs report
- Oil rallies for the week as U.S.-Iran fighting resumes; diesel hits record high
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Alexion Pharma (ALXN) Tops Q4 EPS by 11c, Offers FY Guidance
January 30, 2020 6:32 AM ESTAlexion Pharma (NASDAQ: ALXN) reported Q4 EPS of $2.71, $0.11 better than the analyst estimate of $2.60. Revenue for the quarter came in at $1.38 billion versus the consensus estimate of $1.31 billion.
GUIDANCE:
Alexion Pharma sees FY2020 EPS of $10.65-$10.85, versus the consensus of... More
